Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Wahana Inti Makmur Tbk. (NASI) Price & Performance

Indofarma Tbk.Trade
Wahana Inti Makmur Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Wahana Inti Makmur Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Wahana Inti Makmur Tbk. trades at Rp165 (market cap 131.61B, 4.22M 24h volume). The key difference: Indofarma Tbk. is far larger — about 3× Wahana Inti Makmur Tbk.'s market cap. Which is the better fit depends on your goals.

INAFNASI
Market Cap
390.51B131.61B
Volume
4.22M
Lot
42.25K
Turnover
683.98M
Average Price
161.9
Value
683.98M
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
1.61K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
NASI
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Wahana Inti Makmur Tbk.

PT Wahana Inti Makmur Tbk (the Company) is established based on Deed of Establishment No. 02 dated February 14, 2015 made by Dr. Tio Jeffrens Maranella, S.H., Notary in Jakarta. The Company started its commercial operations in February 2015.

Read more on NASI